Our in vivo data suggest that Rspo rearrangements drive acute hyperproliferation and tumour initiation in the intestine similar to mutational loss of Apc. Yet, our ex vivo transcriptome analysis highlighted marked gene expression differences between Apc-mutant and P-Rspo3 organoids. This evidence concerns the gene RSPO3 and neoplasm.